Skip to main content
TipRanks
Go Ultimate75% OFF

Mechema Chemicals International Corp. (4721) AI Stock Analysis

TW:4721

Mechema Chemicals International Corp.

(TPEx:4721)

Select Model
Rating:63Neutral
Price Target:TWD 70.00â–²(1.74% Upside)
Action:initiatedcoverage
Date:11/10/26

The score is primarily supported by a solid equity base, positive profitability, moderate leverage, and reasonable valuation. However, weakening profitability and substantially lower cash generation are significant risks, while the stock remains in a technically weak trend despite oversold indicators.

Positive Factors
Revenue RecoveryThe return to strong revenue growth indicates that the business recovered from its 2023 weakness and regained operating momentum. If maintained, higher sales can improve scale, support reinvestment, and provide a stronger base for earnings generation over the next several quarters.
Negative Factors
Weaker Cash GenerationThe sharp decline in operating and free cash flow reduces the quality and consistency of recent earnings conversion. Although free cash flow remained positive, weaker cash generation can constrain internally funded investment, dividends, or debt reduction if the deterioration persists.

Mechema Chemicals International Corp. (4721) vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%30%40%50%TW:4721+2.12%SPY+10.92%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 5.19B
Dividend Yield
3.34%
Average Volume (3M)
396.93K
Price to Earnings (P/E)
13.9
Beta (1Y)
1.19
Revenue Growth
7.38%
EPS Growth
85.69%
Country
TW
Employees
237
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Mechema Chemicals International Corp. Business Overview & Revenue Model

Company Description

Mechema Chemicals International Corp. manufactures, imports, exports, and trades sodium acetate, sodium acetate, cobalt compounds, and cobalt compounds, as well as engages in the trading, import, and export of cobalt metal and potassium metal in Taiw...

Mechema Chemicals International Corp. Financial Statement Overview

Summary

Positive revenue growth, earnings, equity, and moderate leverage support the score, but declining margins, net income, debt metrics, and especially operating and free cash flow weaken financial quality.

Income Statement

68Positive

Balance Sheet

78Positive

Cash Flow

52Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.64B2.53B2.12B2.32B5.27B4.13B
Gross Profit644.93M463.10M415.06M234.07M510.76M551.41M
EBITDA539.45M369.94M322.75M144.09M529.60M494.82M
Net Income372.37M225.72M251.92M-24.54M381.32M360.63M
Balance Sheet
Total Assets2.87B2.21B1.90B1.65B2.50B2.44B
Cash, Cash Equivalents and Short-Term Investments560.84M473.10M499.91M213.85M427.59M473.19M
Total Debt1.06B660.17M481.57M399.85M790.17M878.22M
Total Liabilities1.42B858.43M589.21M525.18M1.00B1.06B
Stockholders Equity1.45B1.36B1.31B1.12B1.50B1.38B
Cash Flow
Free Cash Flow-241.84M112.42M258.89M575.56M308.08M-350.61M
Operating Cash Flow-91.67M185.76M297.49M620.60M355.35M-316.12M
Investing Cash Flow-70.89M-46.30M-29.63M-62.21M-63.95M28.92M
Financing Cash Flow238.87M-137.10M-1.02M-735.44M-373.35M495.62M

Mechema Chemicals International Corp. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:4721 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:4746TW:474664NeutralTWD 5.43B11.40―6.64%-2.71%―
TW:4721TW:472163NeutralTWD 5.16B13.89―3.34%7.38%85.69%
TW:6725TW:672560NeutralTWD 5.79B13.09―4.49%――
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:3663TW:366340UnderperformTWD 5.27B138.44―0.82%36.60%147.36%

* General Sector Average

Performance Comparison

0%250%500%750%1000%TW:4721TW:3585TW:3663TW:4746TW:6725TW:7742Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:4721 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:4721Mechema Chemicals International Corp.68.801.331.97%
TW:3585Advance Materials Corporation47.6033.55238.79%
TW:3663ThinTech Materials Technology Co., Ltd.48.552.004.30%
TW:4746Formosa Laboratories, Inc.45.15-13.68-23.26%
TW:6725Cica-Huntek Chemical Technology Taiwan Co156.00-90.57-36.73%
TW:7742Uranus Chemicals Co. Ltd.73.0038.65112.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 10, 2026